Harold A. Sackeim, PhD

TMS in Anxious Depression

January 11, 2023

Patients with anxious depression tend to have more severe depressive symptoms. This study examined the effects of transcranial magnetic stimulation in these patients.

Todd M. Hutton, Scott T. Aaronson, Linda L. Carpenter, et al

Original Research

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

September 16, 2014

David L. Dunner, Scott T. Aaronson, Harold A. Sackeim, et al

Original Research

Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder: A STAR*D Report.

February 15, 2006

Madhukar H. Trivedi, A. John Rush, Stephen R. Wisniewski, et al

Original Research

Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes

September 15, 2005

Ziad Nahas, Lauren B. Marangell, Mustafa M. Husain, et al

Original Research

Predictors of Remission After Electroconvulsive Therapy in Unipolar Major Depression

August 15, 2005

Alexandre Y. Dombrovski, Benoit H. Mulsant, Roger F. Haskett, et al

Original Research

A Computer Algorithm for Calculating the Adequacy of Antidepressant Treatment in Unipolar and Bipolar Depression

July 15, 2003

Maria A. Oquendo, Enrique Baca-García, Alexei Kartachov, et al

Article

The Definition and Meaning of Treatment-Resistant Depression

January 2, 2001

Harold A. Sackeim

Original Research

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

March 31, 1999

M. Lynn Crismon, Madhukar Trivedi, Teresa A. Pigott, et al

Article

Electroconvulsive Therapy and Suicide Risk

February 1, 1999

Joan Prudic, Harold A. Sackeim

TMS in Anxious Depression

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder: A STAR*D Report.

Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes

Predictors of Remission After Electroconvulsive Therapy in Unipolar Major Depression

A Computer Algorithm for Calculating the Adequacy of Antidepressant Treatment in Unipolar and Bipolar Depression

The Definition and Meaning of Treatment-Resistant Depression

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Electroconvulsive Therapy and Suicide Risk

ELSEWHERE:

FOLLOW US:

Harold A. Sackeim, PhD

TMS in Anxious Depression

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder: A STAR*D Report.

Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes

Predictors of Remission After Electroconvulsive Therapy in Unipolar Major Depression

A Computer Algorithm for Calculating the Adequacy of Antidepressant Treatment in Unipolar and Bipolar Depression

The Definition and Meaning of Treatment-Resistant Depression

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Electroconvulsive Therapy and Suicide Risk

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles